Accendra Health Stock ACH
Price
Price
TickerACH
ISINUS6907321029
Accendra Health stock price
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the Accendra Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the Accendra Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the Accendra Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze Accendra Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
| Date | Accendra Health Price |
|---|---|
| 2/18/2026 | 2.45 USD |
| 2/17/2026 | 2.35 USD |
| 2/13/2026 | 2.24 USD |
| 2/12/2026 | 2.28 USD |
| 2/11/2026 | 2.38 USD |
| 2/10/2026 | 2.38 USD |
| 2/9/2026 | 2.39 USD |
| 2/6/2026 | 2.39 USD |
| 2/5/2026 | 2.20 USD |
| 2/4/2026 | 2.32 USD |
| 2/3/2026 | 2.26 USD |
| 2/2/2026 | 2.27 USD |
| 1/30/2026 | 2.21 USD |
| 1/29/2026 | 2.08 USD |
| 1/28/2026 | 2.12 USD |
| 1/27/2026 | 2.10 USD |
| 1/26/2026 | 2.03 USD |
| 1/23/2026 | 2.11 USD |
| 1/22/2026 | 2.11 USD |
| 1/21/2026 | 2.14 USD |
| 1/20/2026 | 2.20 USD |
Accendra Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Accendra Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 1984 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.31 | 0.37 | 0.47 | 0.58 | 0.73 | 0.72 | 0.92 | 1.02 | 1.18 | 1.4 | 2.4 | 2.98 | 3.02 | 3.12 | 3.09 | 3.19 | 3.5 | 3.82 | 3.96 | 4.24 | 4.53 | 4.82 | 5.44 | 6.69 | 7.24 | 8.04 | 8.12 | 8.63 | 8.87 | 9.07 | 9.44 | 9.77 | 9.72 | 9.32 | 9.42 | 9.21 | 8.48 | 9.79 | 9.96 | 10.33 | 10.7 | 2.8 | 2.63 | 2.78 | 3.07 |
| – | 19.93 | 27.25 | 23.34 | 26.91 | -1.50 | 27.22 | 11.46 | 15.28 | 18.69 | 71.44 | 24.26 | 1.44 | 3.21 | -0.83 | 3.37 | 9.67 | 8.91 | 3.77 | 7.20 | 6.62 | 6.56 | 12.84 | 23.03 | 8.20 | 10.96 | 1.07 | 6.20 | 2.79 | 2.29 | 4.07 | 3.52 | -0.50 | -4.17 | 1.07 | -2.21 | -7.93 | 15.39 | 1.74 | 3.81 | 3.54 | -73.86 | -5.97 | 5.55 | 10.66 |
| 12.42 | 11.72 | 10.49 | 9.90 | 9.85 | 9.72 | 9.72 | 9.99 | 10.54 | 10.52 | 9.69 | 8.97 | 9.87 | 10.14 | 10.81 | 10.71 | 10.71 | 10.69 | 10.53 | 10.27 | 10.23 | 10.70 | 9.89 | 9.71 | 10.23 | 10.13 | 9.93 | 9.93 | 10.42 | 12.31 | 12.39 | 12.42 | 12.21 | 12.57 | 11.36 | 12.25 | 15.09 | 15.46 | 18.34 | 20.56 | 20.74 | 79.34 | 84.37 | 79.94 | 72.23 |
| 0.04 | 0.04 | 0.05 | 0.06 | 0.07 | 0.07 | 0.09 | 0.1 | 0.12 | 0.15 | 0.23 | 0.27 | 0.3 | 0.32 | 0.33 | 0.34 | 0.38 | 0.41 | 0.42 | 0.44 | 0.46 | 0.52 | 0.54 | 0.65 | 0.74 | 0.81 | 0.81 | 0.86 | 0.92 | 1.12 | 1.17 | 1.21 | 1.19 | 1.17 | 1.07 | 1.13 | 1.28 | 1.51 | 1.83 | 2.13 | 2.22 | 0 | 0 | 0 | 0 |
| 3 | 4 | 4 | 6 | 8 | 2 | 8 | 12 | 20 | 20 | 4 | -16 | 7 | 19 | 18 | 28 | 33 | 23 | 47 | 53 | 60 | 64 | 48 | 72 | 92 | 103 | 109 | 114 | 108 | 110 | 65 | 102 | 107 | 71 | -437 | -62 | 29 | 221 | 22 | -41 | -362 | 80 | 73 | 91 | 99 |
| – | 33.33 | – | 50.00 | 33.33 | -75.00 | 300.00 | 50.00 | 66.67 | – | -80.00 | -500.00 | -143.75 | 171.43 | -5.26 | 55.56 | 17.86 | -30.30 | 104.35 | 12.77 | 13.21 | 6.67 | -25.00 | 50.00 | 27.78 | 11.96 | 5.83 | 4.59 | -5.26 | 1.85 | -40.91 | 56.92 | 4.90 | -33.64 | -715.49 | -85.81 | -146.77 | 662.07 | -90.05 | -286.36 | 782.93 | -122.10 | -8.75 | 24.66 | 8.79 |
| 28.9 | 36.4 | 41.6 | 42.3 | 42.4 | 42.6 | 43.1 | 44.2 | 44.5 | 46.5 | 47.5 | 46.2 | 47.7 | 48.2 | 48.9 | 58.6 | 59.2 | 60.6 | 61 | 59 | 59.5 | 60.1 | 60.7 | 60.6 | 61.8 | 62.1 | 62.6 | 62.9 | 62.8 | 62.7 | 62.2 | 62.1 | 61.1 | 60 | 60 | 60.6 | 63.5 | 75.49 | 76.22 | 75.79 | 76.74 | 0 | 0 | 0 | 0 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Details
Keystats
ⓘRevenue and Growth
The Accendra Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Accendra Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Accendra Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Accendra Health Stock Sales Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Accendra Health business model
Accendra Health SWOT Analysis
Strengths
Owens & Minor Inc has a strong market presence as a leading distributor of medical and surgical supplies, which provides a competitive advantage in the industry.
The company has a diverse customer base, including hospitals, healthcare systems, and healthcare providers, ensuring a steady stream of revenue.
Owens & Minor Inc has established long-standing relationships with suppliers, enabling favorable terms and access to a wide range of products.
Weaknesses
The company heavily relies on a few key suppliers, which poses a risk to the supply chain and exposes Owens & Minor Inc to potential disruptions in the event of supplier-related issues.
Owens & Minor Inc has significant debt, which can limit financial flexibility and increase interest expense.
The company faces intense competition in the healthcare distribution industry, putting pressure on profit margins.
Opportunities
The COVID-19 pandemic has increased demand for medical supplies, presenting an opportunity for Owens & Minor Inc to capture additional market share and expand revenue.
Growing healthcare expenditure worldwide creates potential for the company to expand its sales globally and diversify its customer base.
The trend towards e-commerce in the healthcare industry opens opportunities for Owens & Minor Inc to enhance its online distribution channels and reach a broader customer segment.
Threats
Possible healthcare reforms and changes in regulations can impact the company's operations and profitability.
Increased pricing pressure from healthcare providers and government agencies could adversely affect Owens & Minor Inc's profit margins.
The emergence of new competitors and consolidation within the industry may intensify competition and potentially decrease market share.
Accendra Health Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
Accendra Health historical P/E ratio, EBIT multiple, and P/S ratio
Accendra Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Accendra Health stock splits
Accendra Health dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Accendra Health dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Accendra Health Earnings Calls
Accendra Health Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 2/25/2026 | 0.22 USD | 721.88 M USD | 2025 Q4 |
| 2/19/2026 | 0.22 USD | 721.88 M USD | 2025 Q4 |
Most common questions regarding Accendra Health
Owens & Minor Inc is a leading global healthcare solutions company. Their business model revolves around providing integrated technologies, products, and services to healthcare providers and manufacturers. With a focus on delivering high-quality and cost-effective solutions, Owens & Minor Inc plays a vital role in the healthcare supply chain. The company's expertise lies in distribution of medical supplies, including surgical and medical instruments, as well as logistics and inventory management services. By partnering with healthcare providers and manufacturers, Owens & Minor Inc ensures efficient operations and helps enhance patient care.
Accendra Health stock
Accendra Health Peer Group
Accendra Health Eulerpool News
Accendra Health Earnings Calls
Accendra Health News
All Accendra Health NewsAccendra Health Ticker
| Stock Exchange | Accendra Health Ticker |
|---|---|
| DÜSSELDORF | 6OM.DU |
| FRANKFURT | 6OM.F |
| MUNICH | 6OM.MU |
| NASDAQ | OMI |
| NEW YORK | OMI |
Accendra Health FIGI
| Accendra Health Ticker | Accendra Health FIGI |
|---|---|
| OMI:US | BBG000CTV5F0 |
| OMI:UA | BBG000CTV5Z8 |
| OMI:UC | BBG000CTV6Y7 |
| OMI:UN | BBG000CTV800 |
| OMI:UP | BBG000CTV8N5 |
| OMI:UB | BBG000CTV9N3 |
| OMI:UT | BBG000CTV9Z0 |
| OMI:UM | BBG000CTVBQ5 |
| OMI:UX | BBG000CTVC74 |
| OMI:UD | BBG000CTVH82 |
| OMI:UF | BBG000CTWL19 |
| OMI:VY | BBG000CTWM35 |
| OMI:VJ | BBG000CTWMR9 |
| OMI:VK | BBG000CTWN60 |
| 6OM:GR | BBG000QJT8R1 |
| 6OM:GF | BBG000QJT9C5 |
| 6OM:GD | BBG000QJT9R9 |
| 6OM:GS | BBG000QJTB30 |
| 6OM:GM | BBG000QJTB58 |
| 6OM:GB | BBG000QJTBQ5 |
| OMI:VF | BBG00DJD5BV8 |
| 6OM:TH | BBG00LSL05Z6 |
| 6OM:QT | BBG00LSZQ6B1 |
| OMI1EUR:XS | BBG00PQ2WSS4 |
| OMI1EUR:XH | BBG00PQ2WSW9 |
| OMI1EUR:XF | BBG00PQ2WSY7 |
| OMI1EUR:XD | BBG00PQ2WSZ6 |
| OMI1EUR:XE | BBG00PQ2WT02 |
| OMI1EUR:XJ | BBG00PQ2WT11 |
| OMI1EUR:XL | BBG00PQ2WT20 |
| OMI1EUR:XG | BBG00PQ2WT39 |
| OMI1EUR:XO | BBG00PQ2WT48 |
| OMI1EUR:XN | BBG00PQ2WT57 |
| OMI1EUR:XA | BBG00PQ2WT84 |
| OMI1EUR:XT | BBG00PQ2WTB0 |
| OMI1EUR:XW | BBG00PQ2WTC9 |
| OMI1EUR:XU | BBG00PQ2WTD8 |
| OMI1EUR:XV | BBG00PQ2WTF6 |
| OMI1EUR:XM | BBG00PQ2WTG5 |
| OMI1EUR:EU | BBG00PQ2WTM8 |
| OMI:VG | BBG00X1LHVQ4 |
| OMI:VP | BBG00X1PY4Q6 |
| OMI1USD:EP | BBG00XR5HQW5 |
| OMI1USD:EZ | BBG00XR5HRD4 |
| OMI1USD:XS | BBG00XR5HRL5 |
| OMI1USD:X2 | BBG00XR5HRM4 |
| OMI1USD:XH | BBG00XR5HRQ0 |
| OMI1USD:XF | BBG00XR5HRT7 |
| OMI1USD:XE | BBG00XR5HRY1 |
| OMI1USD:XJ | BBG00XR5HRZ0 |
| OMI1USD:XL | BBG00XR5HS15 |
| OMI1USD:XG | BBG00XR5HS24 |
| OMI1USD:XO | BBG00XR5HS42 |
| OMI1USD:XA | BBG00XR5HSB4 |
| OMI1USD:E1 | BBG00XR5HSD2 |
| OMI1USD:XT | BBG00XR5HSF0 |
| OMI1USD:XW | BBG00XR5HSG9 |
| OMI1USD:XU | BBG00XR5HSH8 |
| OMI1USD:XV | BBG00XR5HSK4 |
| OMI1USD:XM | BBG00XR5HSL3 |
| OMI1USD:XQ | BBG00XR5HSM2 |
| OMI1USD:XX | BBG00XR5HSN1 |
| OMI1USD:XZ | BBG00XR5HSP9 |
| OMI1USD:X1 | BBG00XR5HSR7 |
| OMI1USD:EU | BBG00XR5HT86 |
| 6OM:GZ | BBG00XTGY208 |
| 6OM:LA | BBG018H92607 |
| 6OM:LU | BBG018J2Q6W9 |
All fundamentals about Accendra Health
Our stock analysis for Accendra Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accendra Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Accendra Health Revenue
- Accendra Health Net Income
- Accendra Health P/E
- Accendra Health P/S
- Accendra Health EBIT
- Accendra Health Dividend
- Accendra Health Directors Dealings
- Accendra Health Stocks
- Accendra Health Market capitalization
- Accendra Health Debt
- Accendra Health Liabilities
- Accendra Health Equity
- Accendra Health AAQS
- Accendra Health Employees
- Accendra Health ROE
- Accendra Health ROA
- Accendra Health ROCE

